Compare STLA & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STLA | RVTY |
|---|---|---|
| Founded | 2021 | 1937 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 17.2B |
| IPO Year | 2014 | 1994 |
| Metric | STLA | RVTY |
|---|---|---|
| Price | $3.37 | $145.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 18 |
| Target Price | $6.39 | ★ $171.40 |
| AVG Volume (30 Days) | ★ 38.1M | 1.6M |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 0.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.38 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $4.94 | $0.55 |
| Revenue Next Year | $2.09 | $5.70 |
| P/E Ratio | ★ N/A | $109.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.49 | $81.22 |
| 52 Week High | $12.22 | $171.74 |
| Indicator | STLA | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 25.65 | 40.69 |
| Support Level | N/A | $109.81 |
| Resistance Level | $6.09 | $169.00 |
| Average True Range (ATR) | 0.16 | 7.32 |
| MACD | -0.09 | -1.67 |
| Stochastic Oscillator | 1.13 | 5.72 |
Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles and French-based Peugeot in January 2021, resulting in the fourth-largest automotive original equipment manufacturer by vehicle sales. In 2025, it sold 5.6 million vehicles, 45%, 26%, and 18% in Europe, North America, and South America, respectively. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroën, Opel, Alfa Romeo, and Maserati.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.